Higher serum MMP7 has been found in IPF compared to other ILDs, as well as in patients with rheumatoid arthritis (RA) with ILD (RA-ILD), and is a marker of progression in IPF and fibrotic hypersensitivity pneumonitis (fHP) [7-9]. Here, MMP7 is linked to interstitial lung disease.